IRRAS Inkomsten in het verleden
We zijn nog bezig met het verwerken van het laatste winstrapport van dit bedrijf
Verleden criteriumcontroles 0/6
IRRAS's earnings have been declining at an average annual rate of -6.1%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 47.2% per year.
Belangrijke informatie
-6.1%
Groei van de winst
38.2%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 4.3% |
| Inkomstengroei | 47.2% |
| Rendement op eigen vermogen | -455.7% |
| Nettomarge | -455.7% |
| Volgende winstupdate | 21 Feb 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe IRRAS geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 23 | 43 | -196 | 153 | 49 |
| 31 Mar 23 | 43 | -193 | 145 | 52 |
| 31 Dec 22 | 40 | -167 | 130 | 46 |
| 30 Sep 22 | 37 | -164 | 120 | 39 |
| 30 Jun 22 | 32 | -141 | 106 | 29 |
| 31 Mar 22 | 27 | -131 | 101 | 24 |
| 31 Dec 21 | 22 | -136 | 93 | 24 |
| 30 Sep 21 | 18 | -131 | 90 | 27 |
| 30 Jun 21 | 14 | -135 | 88 | 29 |
| 31 Mar 21 | 10 | -140 | 87 | 28 |
| 31 Dec 20 | 7 | -136 | 90 | 29 |
| 30 Sep 20 | 8 | -134 | 88 | 28 |
| 30 Jun 20 | 7 | -139 | 87 | 26 |
| 31 Mar 20 | 7 | -147 | 90 | 28 |
| 31 Dec 19 | 5 | -151 | 89 | 30 |
| 30 Sep 19 | 2 | -165 | 102 | 28 |
| 30 Jun 19 | 1 | -171 | 111 | 30 |
| 31 Mar 19 | 0 | -160 | 108 | 29 |
| 31 Dec 18 | 6 | -139 | 103 | 24 |
| 30 Sep 18 | 7 | -112 | 83 | 26 |
| 30 Jun 18 | 18 | -78 | 72 | 17 |
| 31 Mar 18 | 18 | -67 | 66 | 15 |
| 31 Dec 17 | 12 | -61 | 56 | 13 |
| 30 Sep 17 | 11 | -48 | 48 | 7 |
| 31 Dec 16 | 0 | -32 | 27 | 3 |
| 31 Dec 15 | 0 | -13 | 7 | 4 |
Kwaliteitswinsten: 4Z7 is currently unprofitable.
Groeiende winstmarge: 4Z7 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 4Z7 is unprofitable, and losses have increased over the past 5 years at a rate of 6.1% per year.
Versnelling van de groei: Unable to compare 4Z7's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: 4Z7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.2%).
Rendement op eigen vermogen
Hoge ROE: 4Z7 has a negative Return on Equity (-455.69%), as it is currently unprofitable.